Interestingly, monocytes of sarcoidosis patients show an enhanced ability to aggregate in vitro after stimulation with TNF-α and interferon-β, an observation that places TNF in an ambiguous position between one of the factors contributing to the formation of the granuloma or a therapeutic target [49]. The gene discussed is TNF; the disease is Granuloma.